Related Experiment Video
Updated: Aug 25, 2026
Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
Published on: October 14, 2022
Immune reactions associated with silicone-based ventriculo-peritoneal shunt malfunctions in children
Pamela J VandeVord1, Nalini Gupta, Russell B Wilson
1Departments of Pediatric Neurosurgery, Wayne State University School of Medicine, Detroit, MI 48201, USA. pvord@wayne.edu
Insights
Pediatric hydrocephalus patients may experience ventriculo-peritoneal (VP) shunt failure due to immune responses. Antibodies to shunt proteins and biomaterials suggest a link to sterile shunt malfunctions, necessitating further research.
Area of Science:
- Pediatric Neurology
- Immunology
- Biomaterials Science
Background:
- Ventriculo-peritoneal (VP) shunting is a common procedure for pediatric hydrocephalus.
- High rates of shunt failure necessitate frequent revision surgeries.
- The underlying mechanisms of sterile shunt malfunction remain incompletely understood.
Purpose of the Study:
- To investigate the potential role of immune responses in pediatric VP shunt failure.
- To determine if protein deposition and autoantibody formation contribute to shunt malfunction.
- To explore immune reactions to biomaterials and surface proteins of shunts.
Main Methods:
- Analysis of protein deposition on shunts from malfunctioning and functioning VP systems.
- Measurement of autoantibodies against shunt surface proteins.
- Assessment of antibodies targeting polymeric substances, including those cross-reacting with acrylamide.
Main Results:
- Patients with sterile shunt malfunction showed higher protein deposition on shunts.
- Elevated levels of autoantibodies to shunt surface proteins were observed in the malfunction group.
- Antibodies to polymeric substances, potentially linked to biomaterials, were detected in some patients.
Conclusions:
- Immunological responses to shunt-bound proteins and biomaterials may contribute to sterile VP shunt failure in children.
- Further identification of specific antigenic proteins is warranted.
- These findings suggest a novel pathway for understanding and potentially preventing shunt complications.
Abstract:
The implantation of ventriculo-peritoneal (VP) shunting systems is the most commonly performed neurological procedure in children with hydrocephalus. Although the overall complication risk is low, the cumulative risk of shunt failure is high and unfortunately results in a high prevalence of revision surgeries. In this study, we explored the concept that some pediatric patients may develop an immune response to either the proteins attached to the silicone implant surface or to the biomaterial itself, and that this reaction may contribute to VP shunt failure in some individuals. The data displays that the sterile shunt malfunction group had a higher rate of protein deposition and increased levels of autoantibodies to the extracted surface proteins as compared to individuals with functioning shunting systems. The precise nature of the shunt-bound proteins that serve as antigens in this experiment have not yet been determined. The data also indicated that some individuals develop antibodies to polymeric substances that cross-react with partially polymerized acrylamide. The detection of significant amounts of shunt-bound protein, antibody responses to these proteins and to polymeric substances suggest that an immunological response to these proteins may play a role in the mechanism behind sterile shunt malfunctions.